Diabetes Mellitus
10 competing products in clinical development for Diabetes Mellitus.
Pipeline by Phase
Phase 26
Phase 32
Approved2
All Products (10)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pravastatin + Placebo (for Pravastatin) | Daiichi Sankyo | Approved | Completed | 43 |
| Pioglitazone + Rosiglitazone | Eli Lilly | Phase 3 | Completed | 40 |
| Glucagon Nasal Powder + Glucagon Hydrochloride Solution | Eli Lilly | Phase 3 | Completed | 40 |
| Pregabalin + placebo | Astellas Pharma | Approved | UNKNOWN | 39 |
| YH14617 + YH14617 + YH14617 + Placebo | Yuhan | Phase 2 | Completed | 35 |
| prasugrel + Clopidogrel | Daiichi Sankyo | Phase 2 | Completed | 35 |
| ASP8232 + ranibizumab + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| FK614 | Astellas Pharma | Phase 2 | Completed | 35 |
| ipragliflozin + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| placebo + exenatide | Eli Lilly | Phase 2 | Terminated | 27 |